FDA Commissioner Mark McClellan tells NCI audience that science is far from eliminating cancer as a threat.
FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.
Also NIH institute directors earn higher salaries than Vice President Cheney; House subcommittee investigating pay of top NIH officials.
Bush Administration proposes 2.7 percent increase for NIH in fiscal year 2005; NIH budgets listed by institute.
HHS plans network of smoking cessation quitlines.
Funding opportunities listed.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs
